Please use this identifier to cite or link to this item:
https://doi.org/10.1186/1471-2105-7-S5-S17
DC Field | Value | |
---|---|---|
dc.title | Modelling study of dimerization in mammalian defensins | |
dc.contributor.author | Suresh, A | |
dc.contributor.author | Verma, C | |
dc.date.accessioned | 2020-10-20T04:49:04Z | |
dc.date.available | 2020-10-20T04:49:04Z | |
dc.date.issued | 2006 | |
dc.identifier.citation | Suresh, A, Verma, C (2006). Modelling study of dimerization in mammalian defensins. BMC Bioinformatics 7 (SUPPL.5) : S17. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2105-7-S5-S17 | |
dc.identifier.issn | 14712105 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/178008 | |
dc.description.abstract | Background: Defensins are antimicrobial peptides of innate immunity functioning by non-specific binding to anionic phospholipids in bacterial membranes. Their cationicity, amphipathicity and ability to oligomerize are considered key factors for their action. Based on structural information on human ?-defensin 2, we examine homologous defensins from various mammalian species for conserved functional physico-chemical characteristics. Results: Based on homology greater than 40%, structural models of 8 homologs of HBD-2 were constructed. A conserved pattern of electrostatics and dynamics was observed across 6 of the examined defensins; models backed by energetics suggest that the defensins in these 6 organisms are characterized by dimerization-linked enhanced functional potentials. In contrast, dimerization is not energetically favoured in the sheep, goat and mouse defensins, suggesting that they function efficiently as monomers. Conclusion: ?-defensin 2 from some mammals may work as monomers while those in others, including humans, work as oligomers. This could potentially be used to design human defensins that may be effective at lower concentrations and hence have therapeutic benefits. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | Anionic phospholipids | |
dc.subject | Antimicrobial peptide | |
dc.subject | Bacterial membranes | |
dc.subject | Modelling studies | |
dc.subject | Non-specific binding | |
dc.subject | Physicochemical characteristics | |
dc.subject | Structural information | |
dc.subject | Therapeutic benefits | |
dc.subject | Amphipathicity | |
dc.subject | Defensins | |
dc.subject | Innate immunity | |
dc.subject | Mammalian species | |
dc.subject | Structural models | |
dc.subject | Dimerization | |
dc.subject | Monomers | |
dc.subject | Oligomers | |
dc.subject | Phospholipids | |
dc.subject | Bioinformatics | |
dc.subject | Model structures | |
dc.subject | Mammals | |
dc.subject | beta defensin 2 | |
dc.subject | defensin | |
dc.subject | monomer | |
dc.subject | oligomer | |
dc.subject | beta defensin | |
dc.subject | cation | |
dc.subject | DEFB4 protein, human | |
dc.subject | defensin | |
dc.subject | unclassified drug | |
dc.subject | amino terminal sequence | |
dc.subject | article | |
dc.subject | carboxy terminal sequence | |
dc.subject | controlled study | |
dc.subject | dimerization | |
dc.subject | electricity | |
dc.subject | goat | |
dc.subject | human | |
dc.subject | mammal | |
dc.subject | molecular dynamics | |
dc.subject | mouse | |
dc.subject | nonhuman | |
dc.subject | physical chemistry | |
dc.subject | protein function | |
dc.subject | protein interaction | |
dc.subject | protein structure | |
dc.subject | sequence homology | |
dc.subject | sheep | |
dc.subject | animal | |
dc.subject | cell membrane | |
dc.subject | chemical structure | |
dc.subject | chemistry | |
dc.subject | computer simulation | |
dc.subject | genetics | |
dc.subject | metabolism | |
dc.subject | protein quaternary structure | |
dc.subject | sequence alignment | |
dc.subject | site directed mutagenesis | |
dc.subject | Bacteria (microorganisms) | |
dc.subject | Capra hircus | |
dc.subject | Mammalia | |
dc.subject | Ovis aries | |
dc.subject | Animals | |
dc.subject | beta-Defensins | |
dc.subject | Cations | |
dc.subject | Cell Membrane | |
dc.subject | Computer Simulation | |
dc.subject | Defensins | |
dc.subject | Dimerization | |
dc.subject | Humans | |
dc.subject | Mammals | |
dc.subject | Models, Molecular | |
dc.subject | Mutagenesis, Site-Directed | |
dc.subject | Protein Structure, Quaternary | |
dc.subject | Sequence Alignment | |
dc.type | Article | |
dc.contributor.department | BIOLOGY (NU) | |
dc.description.doi | 10.1186/1471-2105-7-S5-S17 | |
dc.description.sourcetitle | BMC Bioinformatics | |
dc.description.volume | 7 | |
dc.description.issue | SUPPL.5 | |
dc.description.page | S17 | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_1471-2105-7-S5-S17.pdf | 7.66 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License